Evidence map›Paper›PMID 36557849›Full record

ArticleMolecules (Basel, Switzerland)2022

Sodium Butyrate Attenuates AGEs-Induced Oxidative Stress and Inflammation by Inhibiting Autophagy and Affecting Cellular Metabolism in THP-1 Cells.

Man Yan, Xiang Li, Chang Sun, Jiajun Tan, Yuanyuan Liu, Mengqi Li, Zishang Qi, Jiayuan He, Dongxu Wang, Liang Wu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Identification of Fibrotic Biomarkers Associated with Macrophages in Diabetic Nephropathy.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  17. Article
  18. Review
  19. Journal of diabetes research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Man YanDepartment of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China.
Xiang LiMedical Laboratory Department, Huai'an Second People's Hospital, Huai'an 223022, China.
Chang SunDepartment of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China.
Jiajun TanDepartment of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China.
Yuanyuan LiuDepartment of Endocrinology, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an 223300, China.ORCID 0000-0003-4411-0562
Mengqi LiDepartment of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China.
Zishang QiDepartment of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China.
Jiayuan HeZhenjiang Center for Disease Control and Prevention, Zhenjiang 212002, China.
Dongxu WangSchool of Grain Science and Technology, Jiangsu University of Science and Technology, Zhengjiang 212100, China.ORCID 0000-0001-7377-6190
Liang WuDepartment of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China.
Jiangsu University · CNXuzhou Medical College · CNJiangsu University of Science and Technology · CNXinjiang Uygur Autonomous Region Disease Prevention and Control Center · CN

Funding

National Natural Science Foundation of China 82000475
6 · The paper itself

Abstract

In recent years, sodium butyrate has gained increased attention for its numerous beneficial properties. However, whether sodium butyrate could alleviate inflammatory damage by macrophage activation and its underlying mechanism remains unclear. The present study used an advanced glycosylation products- (AGEs-) induced inflammatory damage model to study whether sodium butyrate could alleviate oxidative stress, inflammation, and metabolic dysfunction of human monocyte-macrophage originated THP-1 cells in a PI3K-dependent autophagy pathway. The results indicated that sodium butyrate alleviated the AGEs-induced oxidative stress, decreased the level of reactive oxygen species (ROS), increased malondialdehyde (MDA) and mRNA expression of pro-inflammatory cytokines of interleukin (IL)-1β and tumor necrosis factor (TNF)-α, and increased the content of superoxide dismutase (SOD). Sodium butyrate reduced the protein expression of the NLR family, pyrin domain-containing protein 3 (NLRP3) and Caspase-1, and decreased the nucleus expression of nuclear factor-kappaB (NF-κB). Sodium butyrate decreased the expression of light-chain-associated protein B (LC3B) and Beclin-1, and inhibited autophagy. Moreover, sodium butyrate inhibited the activation of the PI3K/Akt pathway in AGEs-induced THP-1 cells. In addition, the metabolomics analysis showed that sodium butyrate could affect the production of phosphatidylcholine, L-glutamic acid, UDP-N-acetylmuraminate, biotinyl-5'-AMP, and other metabolites. In summary, these results revealed that sodium butyrate inhibited autophagy and NLRP3 inflammasome activation by blocking the PI3K/Akt/NF-κB pathway, thereby alleviating oxidative stress, inflammation, and metabolic disorder induced by AGEs.

Indexed as

NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinButyric AcidGlycation End Products, AdvancedHumansInflammasomesInflammationOxidative StressPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesSignal TransductionTHP-1 CellsTumor Necrosis Factor-alphaButyric AcidGlycation End Products, AdvancedInflammasomesNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesTumor Necrosis Factor-alphaadvanced glycation end productscellular metabolismdiabetic nephropathyinflammatory damagesodium butyrate

Identifiers

PMID36557849
PMCPMC9781837
OpenAlexW4311960065

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.